Objective: To investigate the effect of exogenous gonadotropins on the expression of transforming growth factor (TGF) b 1 and b 2 in the rat uterus and its consequences for successful embryo implantation. Design: Controlled experimental research study. Setting: School of Anatomical Sciences, University of the Witwatersrand. Patient(s): Thirty-six adult, virgin, female Sprague-Dawley rats and two fertile males. Intervention(s): Follicle-stimulating hormone (FSH) and human chorionic gonadotropin (hCG) were superimposed upon the normal hormonal milieu of normal, cycling female rats before mating. Uterine tissue was collected at peri-implantation stages (i.e., at 4.5, 5.5, and 6.5 days) after mating. Enzyme-linked immunosorbent assay (ELISA) was performed to estimate the blood estrogen and progesterone levels, and immunohistochemistry was performed to localize the TGF-b 1 and TGF-b 2 in the uterus. Main Outcome Measure(s): Hyperstimulation affecting the expression of both TGF-b 1 and TGF-b 2 during the peri-implantation period.
Hyperstimulation, the artificial induction of superovulation by the administration of exogenous hormones, is routinely used in assisted reproductive technologies to produce increased numbers of oocytes (1, 2) . It has been shown that exogenous hormones such as follicle-stimulating hormone (FSH) and human chorionic gonadotropin (hCG) cause adverse changes in the endogenous hormonal milieu as well as in the morphologic and molecular endometrial environment (3) (4) (5) (6) (7) (8) . In addition, changes have also been noted in the implanting embryo after hyperstimulation (9, 10) , altering the conditions necessary for normal implantation.
The uterus/endometrium, being an end organ for the signals derived from the hypothalamic-pituitary-ovarian axis, is under the control of the ovarian steroids estrogen and progesterone. After estrogen-induced cell proliferation, progesterone promotes cell differentiation within the endometrium, establishing a receptive environment for implantation of the semi-allogenic embryo (11) (12) (13) (14) (15) (16) . This delicate coordination of endogenous hormone levels involves the synchronized production of corresponding molecules, which bind the apical uterine epithelium and the trophectoderm surface of the implanting embryo, resulting in the attachment of the two opposing membranes. This is the initial event that will result in successful implantation (17) . The importance of the molecular members that make the endometrium receptive to implantation are gradually being recognized because some cases of unexplained infertility are believed to be due to disrupted endometrial function and alterations in the molecular repertoire that are crucial for implantation (18) .
Transforming growth factor betas (TGF-bs) are multifunctional growth factors that regulate many aspects of cellular activities including cell growth, proliferation, and differentiation, tissue remodeling, extracellular matrix formation, control of cell surface molecules, immunoregulation, angiogenesis, and apoptosis (19, 20) . Potential roles of TGF-bs have been identified in gonad and secondary sex organ development, spermatogenesis, and ovarian function, immunoregulation of pregnancy, embryo implantation, and placental development (19) . Because embryo-uterine interactions during the process of implantation involve each of these processes, it appears that these growth factors may play an important role during the periimplantation period (21, 22) .
Messenger RNA (mRNA) for TGF-b 1 has been shown to be present within the uterus during pregnancy in the rat and to be localized to the luminal and glandular epithelial cells during early and late pregnancy (23) . Both TGF-b 1 and TGF-b 2 mRNA are also found in the luminal and glandular epithelia of the mouse uterus on days 1 to 4 of pregnancy (i.e., before implantation) as well as in the extracellular matrix of the stroma and decidual cells (24, 25) . During the peri-implantation period, mRNA for TGF-b 2 was found in the luminal and glandular epithelia, myometrium, and decidua of the mouse uterus, and TGF-b 3 was found to be mostly localized to the myometrium (22) . Shooner et al. (26) demonstrated the up-regulation of TGF-b 1 and TGF-b 2 expression on days 5.5 and 6.5 of pregnancy in the stromal compartment at the implantation site in the rat.
Our investigation determined whether the administration of exogenous gonadotropins (FSH and hCG) that have a luteinizing effect (and which together cause hyperstimulation and superovulation) adversely affect the expression of TGF-b 1 and TGF-b 2 in the rat uterus during the peri-implantation period. Differences in the normal expression of these growth factors in the uterus after hyperstimulation may indicate the requirement for transforming growth factors in successful embryonic implantation. Thirty-six adult, virgin, female Sprague-Dawley rats weighing between 200 and 250 g and two male rats of proven fertility were housed in the animal unit of the University of the Witwatersrand. The animals had free access to food and water and were maintained at a constant temperature of 22 C. A regular 12-hour day and 12-hour night cycle was also maintained. Vaginal smears of the female rats were taken daily until a regular 4-day estrus cycle had been established. Only those animals showing at least three consecutive, regular 4-day cycles were used in the study. The 36 female rats were divided into six groups of six animals each. Three groups (n ¼ 18) represented the control animals, and the other three groups were the experimental groups (n ¼ 18) that underwent hyperstimulation. After mating and establishing of the vaginal plugs or spermatozoa in the vaginal smears, animals from both experimental (hyperstimulated) and control groups were further divided into groups of six animals each. Each group represented a different stage of pregnancy, namely, 4.5, 5.5, and 6.5 days.
MATERIALS AND METHODS

Experimental Group
In the experimental groups (n ¼ 18), each animal received an intraperitoneal injection of 20 IU of FSH (Folligon; Intervet S.A., Johannesburg, South Africa) at mid-day of mid-diestrus followed by an intraperitoneal injection of 20 IU of hCG (Chorulon; Intervet S.A.) 24 hours later (i.e., at mid-day of late diestrus) (4). Because it has been shown that the endometrial changes in the human female and in the rat are very similar at the time of implantation (27) , we hyperstimulated the female rats in phase with the estrus cycle to simulate conditions comparable with human in vitro fertilization (IVF). Hyperstimulation results in the increased secretion of the ovarian hormones and the subsequent increase in production of oocytes (superovulation).
Control Group
Each control animal (n ¼ 18) received an intraperitoneal injection of 0.1 mL of sterile saline at mid-day of mid-diestrus followed by an intraperitoneal injection of 0.3 mL of sterile saline 24 hours later (i.e., at mid-day of late diestrus). The volumes of the sterile saline given to the control animals at mid-diestrus and late diestrus were the same as the volumes of exogenous gonadotropins that were administered to the hyperstimulated animals at the relevant time of the estrus cycle.
All animals from both the experimental and control groups were mated with proven fertile males on the evening of the day when they received the second injection (i.e., when they were in proestrus). The morning after mating was taken as day 0.5 of pregnancy. The presence of a mucous vaginal plug or spermatozoa in the vaginal smears on the morning after mating indicated successful copulation. Animals in both the experimental and control groups were killed on days 4.5, 5.5, and 6.5 of pregnancy (the peri-implantation period). Rats were anesthetized with a mixture of 0.6 mL of Chanazine (Centaur Labs, Johannesburg, South Africa) and 0.24 mL of ketamine (Centaur Labs).
Heart punctures were performed, and blood (5 mL) from the ventricle of each animal was collected and immediately centrifuged. The plasma was stored at -70 C for an enzyme-linked-immunosorbent assay (ELISA) to estimate blood estrogen and progesterone levels at the time of death.
The pontamine blue technique was used to demonstrate implantation sites (28) . The inferior vena cava was surgically exposed, and a 1% pontamine blue solution (0.5 mL) was injected into the vessel and allowed to circulate for 10 to 15 minutes to localize the implantation sites. The uterine horns were removed. Implantation sites (blue bands) were dissected out and fixed for 24 hours in 10% neutral buffered formalin solution. Tissues were then dehydrated through a graded series of alcohols, cleared in chloroform, and embedded in paraffin wax. Tissues were maintained at room temperature until routine histologic examination and immunohistochemical localization of specific antigens were performed.
Progesterone and Estradiol ELISA An ELISA was carried out to determine the plasma concentrations of estradiol and progesterone by using an estradiol (E 2 ) and a progesterone (P) enzyme immunoassay test kit (Linear Chemicals, Montgat, Spain). A standard curve was obtained by plotting the concentration of the standard versus the absorbance. The E 2 and P concentration of the specimens and the controls were run concurrently with standards and were calculated from the standard curve. The P/E 2 ratio was calculated by dividing the P value in nm/mL by the E 2 value in nm/mL Â 10
À3 .
An unpaired Student's t-test as well as the nonparametric Mann-Whitney test were used for the statistical analysis of the plasma concentrations for progesterone and estradiol and comparisons between the control and hyperstimulated animal groups.
Histology
Paraffin wax embedded uteri were cut at 4 mm, and the sections were placed on glass slides coated with silane. Sections were deparaffinized in xylene, rehydrated in a series of graded alcohols, and then stained with hematoxylin and eosin for routine histologic assessment. Uterine tissue sections were analyzed by light microscopy with the Zeiss Axioscope microscope (Axioscope 2, MOT, Carl Zeiss, Jena, Germany). Suitable images were taken with the digital camera (Sony 3CCD; Sony, Thornwood, NY) attached to the Axioscope.
Immunohistochemistry
Uterine tissue sections 4 mm thick were mounted on silanecoated slides. The sections were deparaffinized, rehydrated, and then heated for 2 Â 5 minutes in 10 mM citrate buffer, pH 6.0, containing Triton X-100 (Sigma-Aldrich, St. Louis, MO) 0.1% (v/v). Sections were washed in running water and Tris-buffered saline (TBS), pH 7.6, containing Triton X-100 and then incubated with 0.3% hydrogen peroxide in distilled water for 30 minutes to quench any endogenous peroxidase activity. The sections were incubated with normal blocking serum (Vectastain Elite ABC Kit; Vector Laboratories, Hercules, CA) at room temperature for 1 hour. Then the primary antibody diluted in TBS (TGF-b 1 or TGF-b 2 ; 1:100 dilution; Santa Cruz Biotechnology, Santa Cruz, CA) was added to the sections and incubated at 4 C overnight in a humidified chamber.
Sections were incubated for 30 minutes with biotinylated secondary antibody (anti-rabbit, Vectastain Elite ABC Kit; Vector Laboratories). Subsequently, sections were washed with TBS for 3 Â 5 minutes and incubated with an avidin-biotin complex reagent containing horseradish peroxidase for 30 minutes. Color development was achieved by applying a diaminobenzidine (DAB) substrate for 5 minutes. Sections were then washed in running water for 5 minutes, counterstained with hematoxylin, and mounted in Entellan (Merck, Darmstadt, Germany).
Immunocytochemistry Controls
Negative controls were performed by substituting TBS or normal rabbit serum (NRS) for either the primary or secondary antibody, respectively, and were always performed on a section adjacent to the section of uterine tissue that showed immunolocalization. For absorption controls, absorption of the primary antibody with the purified antigen was used to show specificity of the antibody. The primary antibody was preabsorbed with its own antigen (blocking peptide sc-146 P for TGF-b 1 and sc-90 P for TGF-b 2 
RESULTS
General Observation
Postmortem examination of the uterine horns showed distinct gross morphologic differences between the control and hyperstimulated animals. The uterine horns of the control animals at 5.5 and 6.5 days of pregnancy showed numerous implantation sites (8 to 15 per animal), which were indicated by blue bands after the injection of the pontamine blue dye. Only one control animal at 4.5 days of pregnancy showed three implantation sites as indicated by the pontamine blue technique. The uterine horns in the hyperstimulated animals at 4.5, 5.5, and 6.5 days of pregnancy were noticeably dilated when compared with control animals at the same stages of pregnancy. The majority of the experimental animals from all three stages of pregnancy did not show blue-stained implantation sites. However, two animals in the hyperstimulated group at 5.5 days of pregnancy showed one visible implantation site per animal.
Progesterone ELISA
The mean progesterone level for control animals (Fig. 1A) showed a statistically nonsignificant increase between 4.5 and 5.5 days of pregnancy (P¼.054), followed by a statistically nonsignificant decrease on day 6.5 of pregnancy (P¼.060). However, in the hyperstimulated animals, the progesterone plasma concentrations increased gradually from 4.5 days through 6.5 days of pregnancy (see Fig. 1A ), but this was again not statistically significant (P¼.362 and P¼.213, respectively).
Higher concentrations of plasma progesterone were evident within the hyperstimulated group when compared with the controls, but the concentrations were only statistically significantly higher at 6.5 days of pregnancy (P¼.006) (see Fig. 1A ). No statistically significant differences were found when progesterone plasma concentrations were compared between the control and hyperstimulated animals at 4.5 days (P¼.362) or at 5.5 days (P¼.213) of pregnancy.
Estradiol ELISA
obtained from the fifth sample was discarded because it was extremely different (66.60 pg/mL) from the values obtained from the other animals at the same stage of pregnancy. Variability may have been due to variations in the time at which this animal was killed with respect to the other animals in this group. The sixth sample discarded was highly hemolyzed and thus not suitable for the test.
In the control group (see Fig. 1B ), the estradiol levels did not show a statistically significant increase from 4.5 to 5.5 days of pregnancy (P¼.816) or from 5.5 to 6.5 days of pregnancy (P¼.164).
In the hyperstimulated group (see Fig. 1B ), the estradiol plasma concentrations were not statistically significantly higher at 5.5 days of pregnancy when compared with those at 4.5 days of pregnancy (P¼.632). However, a statistically significant decrease in estradiol plasma concentrations was observed in animals at 6.5 days of pregnancy when compared with those at 4.5 and 5.5 days of pregnancy (P¼.038).
No statistically significant higher concentrations of plasma estradiol were obvious in the hyperstimulated groups at 4.5 (P¼.249) and 5.5 (P¼.117) days of pregnancy when compared with the control animals at the same stages (see Fig.  1B ). However, statistically significantly lower estradiol levels were found in the hyperstimulated group when compared with the control group at 6.5 days of pregnancy (P¼.039).
Progesterone-Estradiol (P:E 2 ) ratio The P:E 2 ratio was calculated by dividing the P value in nm/ mL by the E 2 value in nm/mL Â 10 À3 . When comparing the P:E 2 ratio between the control and hyperstimulated groups, a slight increase was observed between 4.5 and 5.5 days of pregnancy (see Fig. 1C ). However, at 6.5 days of pregnancy, the P:E 2 ratio showed a marked decrease (i.e., estrogen was dominant) in the control group while in the hyperstimulated group the opposite occurred. The dominance of progesterone was noticeable and was demonstrated by a marked increase in the P:E 2 ratio (see Fig. 1C ).
Histology
Distinct differences were observed between control and hyperstimulated animals at all three stages of pregnancy. Most of the changes that followed hyperstimulation, such as the dilated uterine lumina, folded luminal epithelium, or flat and fibroblastic subepithelial stromal cells, have been previously reported elsewhere (4, 6, 7) . In addition, in the our study, the lumina of the glands of the hyperstimulated animals were observed to be more dilated at 5.5 and 6.5 days of pregnancy than the lumina of the glands in the control groups at the same stages of pregnancy (figure not shown).
FIGURE 1
Graphs representing progesterone and estrogen concentrations and P:E 2 ratio between control and hyperstimulated animals on the different days of pregnancy. (A) Progesterone concentrations (ng/mL) in control (pink columns) and hyperstimulated animals (gray columns) on different days of pregnancy. (B) Estrogen concentrations (pg/ mL) in the control (purple columns) and hyperstimulated animals (gray columns) on different days of pregnancy. (C) Ratio between progesterone and estradiol plasma concentrations (P:E 2 Â 10 À3 ) in control (green line) and hyperstimulated (gray line) animals on different days of pregnancy.
Jovanovi c. Hyperstimulation and rat uterus TGF-b. Fertil Steril 2010.
Immunocytochemistry
All immunocytochemical control procedures provided satisfactory results indicative of specificity of the primary antisera. In those sections in which the primary or secondary antibodies were omitted or in which the primary antibody (TGF-b 2 ) was absorbed with its own antigen, no immunolabeling was detected. However, in the case of TGF-b 1 slight immunolabeling persisted despite the fact that the amount of blocking peptide was increased 25 times (by weight) following the recommendation of Santa Cruz Biotechnology.
Immunolocalization of TGF-b 1 in Control and Hyperstimulated Animals at 4.5, 5.5, and 6.5 Days of Pregnancy At all three stages of pregnancy in control and hyperstimulated animals, TGF-b 1 immunolocalization was weak in both the luminal and glandular epithelial cells. However, immunolocalization of the antibody was much stronger in the stromal compartment of the hyperstimulated animals ( Fig. 2B and D) and showed distinct zonation (see Fig. 2B and D). The immediately subluminal stromal zone had weaker immunolocalization of TGF-b 1 while the deeper stromal region had a more marked expression (see Fig. 2B and D). This was not evident in the control groups (see Fig. 2A and C). However, the subluminal stromal cells at the antimesometrial side of the control (pregnant) uteri showed stronger expression of TGF-b 1 than those at the mesometrial side at 5.5 and 6.5 days of pregnancy. This was particularly evident at 6.5 days of pregnancy in the control animals in the vicinity of the implantation sites (see Fig. 2C ). Increased localization of TGF-b 1 was not detected in the antimesometrial region in the hyperstimulated animals at any stage. Immunolocalization of TGF-b 2 in Control and Hyperstimulated Animals at 4.5, 5.5, and 6.5 Days of Pregnancy The immunolocalization of TGF-b 2 was strong in the luminal epithelium, stroma (Fig. 3A) , and glandular epithelium in the control animals at 4.5 days of pregnancy but decreased gradually in all of these areas as the pregnancy progressed (figure not shown). Localization of this antibody was weak in the luminal epithelium and particularly strong in the glandular epithelial cells on all 3 days of pregnancy in the hyperstimulated group (see Fig. 3D ) when compared with the controls (see Fig.  3C ). Zonation of TGF-b 2 immunolocalization in the stroma was not observed in the control groups at any of the three stages of pregnancy, but was evident in the stroma of the hyperstimulated animals. The deeper stromal zone of the hyperstimulated animals expressed stronger immunolocalization than the immediate subluminal stroma at days 4.5 and 5.5 of pregnancy (see Fig. 3B ), but at 6.5 days of pregnancy, TGF-b 2 immunolocalization in the stroma was absent.
At 6.5 days of pregnancy (control animals), the implantation chamber was surrounded by decidualizing stromal cells, which showed intense expression of TGF-b 2 . No immunolocalization of TGF-b 2 was detected in the flattened luminal epithelial cells or the blastocyst.
DISCUSSION
The preparation of the endometrium for receipt of the embryo depends on the ovarian hormones estrogen and progesterone. In our study, the secretion of estrogen and progesterone from the ovaries was affected by the administration of exogenous gonadotropins. As a consequence, the release of progesterone was comparatively higher in all three examined groups, while estradiol levels increased from 4.5 to 5.5 days of pregnancy followed by a sudden drop between 5.5 and 6.5 days of pregnancy. This altered the hormonal profile observed in the hyperstimulated animals severely affected the number of the implanting embryos as indicated by the pontamine bluestained implantation sites.
When comparisons were made between the control and the hyperstimulated groups at all three stages of pregnancy, the values of both the circulating levels of progesterone and estradiol were higher in the latter group, but were only statistically significantly higher in the case of progesterone at 6.5 days of pregnancy and lower in the case of estradiol at 6.5 days.
Premature elevations in plasma progesterone levels after routine use of hCG in IVF programs induces an unexpected and markedly increased secretion of progesterone (29) . This sudden shift in the progesterone level accelerates the secretory changes of the endometrium to the point of phasing out endometrial receptivity and embryo development (29) . As progesterone levels increased in the hyperstimulated animals during the peri-implantation period, this event could have shifted the window of implantation earlier in the treated animals, thus causing dyssynchrony between the maturity of the embryo and receptivity of the endometrium.
The findings of our study of higher estrogen levels in the hyperstimulated animals are consistent with Ma et al. (30) and Basir et al. (31) , who showed that the uterus becomes refractive and morphologically altered following raised estrogen levels due to hyperstimulation. Thus, the absence of implantation sites in the majority of the treated animals could be due to the change in the estrogen levels after ovarian hyperstimulation.
After hyperstimulation, estradiol levels increased before implantation (day 5.5), followed by a rapid decrease at 6.5 days of pregnancy. The progesterone plasma concentrations were also affected by the treatment and showed a gradual increase from 4.5 day onward. Consequently, the P:E 2 ratio was lower in the hyperstimulated group than in the control animals before implantation, and only statistically significantly higher at 6.5 days of pregnancy. According to Gidley-Baird et al. (32) , alterations in estrogen and progesterone levels affect the reproductive outcome, and the P:E 2 ratio better predicts the implantation outcome than the absolute levels of either estrogen or progesterone alone (30, 32) . Our findings are consistent with the work previously done by Gidley-Baird et al. (32) and Kramer et al. (3) in which they showed that a change in the P:E 2 ratio had detrimental effects on the number of implanting embryos in the mouse and rat, respectively.
Immunohistochemical analysis showed marked differences in the expression of both TGF-b 1 and TGF-b 2 between the control and hyperstimulated animals. Hyperstimulation appears to have caused two zones of expression of TGF-b 1 and TGF-b 2 in the stromal compartment when compared with the control uteri. However, hyperstimulation did not influence the expression of TGF-b 1 in the luminal and glandular epithelium; differences were not observed between the control and hyperstimulated animals in any of the examined stages of pregnancy. The most prominent effect of hypertstimulation with regards to TGF-b 2 was its up-regulated expression in the glandular epithelial cells in all examined stages of pregnancy when compared with the control animals.
The variation in the expression of both TGF-b 1 and TGFb 2 in our study is not surprising, as the transforming growth factors present multifunctional cytokines that are dynamically expressed in the endometrium. Through their actions, TGF-bs are associated with cell proliferation, differentiation, apoptosis, angiogenesis, tissue remodeling, and immune responses (16) . Because of the involvement that TGF-bs have in the cellular and molecular processes such as those mentioned previously, these polypeptides are thought to play an important role in modulating cellular events involved in menstruation, decidualization, trophoblast attachment, immunotolerance, and embryogenesis. They also have unique roles in embryo-uterine interactions during implantation (20) . Estrogen and progesterone have previously been shown to regulate changes in the endometrium and stroma of pregnant and nonpregnant uteri. The actions of these steroid hormones are usually not direct but rather are mediated through their stimulatory or inhibitory effects upon different endometrial cells and/or molecules such as TGF-bs (24, 33, 34) .
In their study on the expression of different TGF-b isoforms in the mouse uterus and the effects that ovarian steroids have on these growth factors during the peri-implantation period, Das et al. (20) explained that different mechanisms are involved in the production of TGF-bs in this organ. Similarly, in their study on the mammary gland concerning the activation of TGF-b by ovarian hormones, Ewan et al. (35) showed that during the periods of proliferation (i.e., puberty, estrus, and pregnancy, which are under control of ovarian hormones), TGF-b 1 activation decreased in some cells, consistent with preparation for proliferation. In contradiction, other cells simultaneously increased TGF-b 1 immunoreactivity. Ewan et al. (35) explained that this switch in the synthesis indicates that ovarian hormones regulate TGF-b 1 activation, which in turn restricts the proliferative response to hormone signaling.
In the light of the results obtained by Ewan et al. (35) , the regionalization in the expression of TGF-b 1 and TGF-b 2 (i.e., the presence of two zones in the stroma of the hyperstimulated animals) may have occurred as a result of raised estrogen and progesterone levels, which in turn influenced the response of the stromal cells. Consequently, the altered stromal environment ''during the window of implantation'' contributed to the unfavorable state of the uterus for embryo implantation.
Control animals showed TGF-b 1 expression at the antimesometrial pole, which was not observed in the hyperstimulated animals. Moulton (36) showed that the TGF-b 1 and TGF-b 2 treatment induced apoptosis in cultured rat endometrial stromal cells as well as controlled apoptosis in the rat uterus during early pregnancy. Thus, the findings of our study showing localization of TGF-b 1 and TGF-b 2 at the antimesometrial side of the uterine lumen and around the implanting conceptus in the control animals but not in the hyperstimulated animals suggest that both TGF-b 1 and TGF-b 2 may play a role in the initiation of embryo implantation as well as in apoptosis.
Hyperstimulation provided an unfavorable environment for embryo implantation by totally inhibiting the presence of TGF-b 1 and TGF-b 2 at the implantation sites.
Apoptosis is said to be a crucial event in the physiology of endometrial stroma of normal cycling as well as pregnant uteri, which enables the trophoblast cells to gain access to the maternal blood vessels (36, 37) . Pampfer and Donnay (38) and Abrahamsohn and Zorn (39) observed some morphologic characteristics of apoptosis in endometrial epithelial cells at embryo implantation sites in rodents. Transforming growth factor b 1 both inhibits cell proliferation and increases apoptosis of uterine epithelial cells in culture (40) , and TGFb 2 secretion by endometrial cells controls stromal apoptosis during early pregnancy in vitro (36) . Shooner et al. (26) indicated that both TGF-b 1 and TGF-b 2 were found in epithelial and stromal cells during early pregnancy in the rat. In addition, Moulton (36) exposed stromal cells to steroid treatment for the experimental induction of decidualization, which caused, according to Lea et al. (25) , a switch from TGF-b 1 expression to TGF-b 2 . This suggests that TGF-b 2 may be more involved than the TGF-b 1 isoform in inducing apoptosis of the rat decidua. Indeed, results obtained from our study support findings made by Lea et al. (25) and Chatzaki et al. (37, 41) because, although TGF-b 1 was present around implantation chambers, the immunolocalization potency of the TGF-b 2 isoform and its spatial and temporal expression were more pronounced than the TGF-b 1 isoform.
Despite the fact that hyperstimulation with exogenous gonadotropins is effective in multiple follicular development, there is growing evidence of the deleterious effects of this procedure on the uterine endometrium around the time of implantation. The results of our investigation suggest that exogenous administration of FSH and hCG, which has been routinely used in IVF and embryo transfer programs, interferes with the normal expression of TGF-b 1 and TGF-b 2 , whose actions are necessary for normal endometrial development in preparation for embryo implantation and successful pregnancy. This is yet another important consideration that needs to be addressed when assessing the low pregnancy rate in assisted reproductive programs.
